Filing Details
- Accession Number:
- 0001209191-14-025801
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-03 19:52:48
- Reporting Period:
- 2014-04-01
- Filing Date:
- 2014-04-03
- Accepted Time:
- 2014-04-03 19:52:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206199 | G Daniel Welch | 3280 Bayshore Boulevard Brisbane CA 94005 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-04-01 | 3,673 | $33.57 | 98,106 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $33.50 to $33.68 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Reflects the corrected number of shares upon the sale of 20,000 shares on February 3, 2014.
Billionaire Hedge Funds
